152 related articles for article (PubMed ID: 16872654)
1. Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.
Silva WP; Santos DE; Leal E; Brunstein A; Sucupira MC; Sabino EC; Diaz RS
Virology; 2006 Oct; 354(1):35-47. PubMed ID: 16872654
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: an analysis of tat and C2-V3 env regions.
Sabino E; Pan LZ; Cheng-Mayer C; Mayer A
AIDS; 1994 Jul; 8(7):901-9. PubMed ID: 7946099
[TBL] [Abstract][Full Text] [Related]
3. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function.
Vecchi M; Burighel N; Bellanova D; Menzo S; De Rossi A; Clementi M; Bagnarelli P
New Microbiol; 2004 Apr; 27(2 Suppl 1):99-104. PubMed ID: 15646071
[TBL] [Abstract][Full Text] [Related]
5. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
6. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.
Frost SD; Günthard HF; Wong JK; Havlir D; Richman DD; Leigh Brown AJ
Virology; 2001 Jun; 284(2):250-8. PubMed ID: 11384224
[TBL] [Abstract][Full Text] [Related]
7. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy.
Brown AJ; Cleland A
AIDS; 1996 Sep; 10(10):1067-73. PubMed ID: 8874622
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia.
Martínez MA; Cabana M; Ibáñez A; Clotet B; Arnó A; Ruiz L
Virology; 1999 Apr; 256(2):180-7. PubMed ID: 10191182
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users.
Saraswathy TS; Ng KP; Sinniah M
Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):283-6. PubMed ID: 11127327
[TBL] [Abstract][Full Text] [Related]
10. Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.
Ibáñez A; Clotet B; Martínez MA
Virology; 2001 Mar; 282(1):1-5. PubMed ID: 11259184
[TBL] [Abstract][Full Text] [Related]
11. High resolution analysis of HIV-1 quasispecies in the brain.
Monken CE; Wu B; Srinivasan A
AIDS; 1995 Apr; 9(4):345-9. PubMed ID: 7794539
[TBL] [Abstract][Full Text] [Related]
12. Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1.
Kupfer B; Sing T; Schüffler P; Hall R; Kurz R; McKeown A; Schneweis KE; Eberl W; Oldenburg J; Brackmann HH; Rockstroh JK; Spengler U; Däumer MP; Kaiser R; Lengauer T; Matz B
J Med Virol; 2007 Nov; 79(11):1629-39. PubMed ID: 17854039
[TBL] [Abstract][Full Text] [Related]
13. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
[TBL] [Abstract][Full Text] [Related]
14. An immune control model for viral replication in the CNS during presymptomatic HIV infection.
McCrossan M; Marsden M; Carnie FW; Minnis S; Hansoti B; Anthony IC; Brettle RP; Bell JE; Simmonds P
Brain; 2006 Feb; 129(Pt 2):503-16. PubMed ID: 16317019
[TBL] [Abstract][Full Text] [Related]
15. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain.
Pérez-Alvarez L; Muñoz M; Delgado E; Miralles C; Ocampo A; García V; Thomson M; Contreras G; Nájera R;
J Med Virol; 2006 Dec; 78(12):1520-8. PubMed ID: 17063519
[TBL] [Abstract][Full Text] [Related]
16. Seminal reservoirs during an HIV type 1 eradication trial.
Nunnari G; Leto D; Sullivan J; Xu Y; Mehlman KE; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2005 Sep; 21(9):768-75. PubMed ID: 16218800
[TBL] [Abstract][Full Text] [Related]
17. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
[No Abstract] [Full Text] [Related]
18. Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection.
Chamberland A; Sylla M; Boulassel MR; Baril JG; Côté P; Thomas R; Trottier B; Rouleau D; Routy JP; Tremblay C;
Int J STD AIDS; 2011 Mar; 22(3):146-50. PubMed ID: 21464451
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.
Benson CA; Vaida F; Havlir DV; Downey GF; Lederman MM; Gulick RM; Glesby MJ; Wantman M; Bixby CJ; Rinehart AR; Snyder S; Wang R; Patel S; Mellors JW;
J Infect Dis; 2006 Nov; 194(9):1309-18. PubMed ID: 17041858
[TBL] [Abstract][Full Text] [Related]
20. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml.
Kupfer B; Matz B; Däumer MP; Roden F; Rockstroh JK; Qurishi N; Spengler U; Kaiser R
J Med Virol; 2007 Oct; 79(10):1440-5. PubMed ID: 17705170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
